Ποια είναι η τιμή για IBEX Technologies Inc. (IBT)

Η τιμή για IBEX Technologies Inc. (IBT) είναι $1.05

Ποια είναι η κεφαλαιοποίηση αγοράς για IBEX Technologies Inc. (IBT)

Η κεφαλαιοποίηση αγοράς για IBEX Technologies Inc. (IBT) είναι $23.31M

IBEX Technologies Inc. (IBT) Τιμή και Κεφαλαιοποίηση Αγοράς

Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.

Η τιμή για IBT	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$239,280 $23.31M	NVDA	$5.301T	+22,742,553.94%
$209,172 $23.31M	AAPL	$4.634T	+19,880,881.49%
$187,021 $23.31M	GOOG	$4.143T	+17,775,561.67%
$162,024 $23.31M	MSFT	$3.589T	+15,399,616.19%
$128,962 $23.31M	AMZN	$2.857T	+12,257,249.99%

Η τιμή για IBT

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$239,280 $23.31M